Treatment of visceral leishmaniasis.
作者信息
Ozsoylu Sinasi
出版信息
Turk J Pediatr. 2003 Jul-Sep;45(3):280.
PMID:14696814
Abstract
摘要
相似文献
1
Treatment of visceral leishmaniasis.
Turk J Pediatr. 2003 Jul-Sep;45(3):280.
2
Visceral leishmaniasis and Coombs' positive hemolytic anemia: a rare association in an infant treated with liposomal amphotericin B.
Turk J Pediatr. 2002 Oct-Dec;44(4):354-6.
3
Immune mediated hemolysis in visceral leishmaniasis.
J Trop Pediatr. 2007 Aug;53(4):284-6. doi: 10.1093/tropej/fmm018. Epub 2007 May 4.
4
Kala-azar associated with coombs-positive autoimmune hemolytic anemia in the patients coming from the endemic area of this disease and successful treatment of these patients with liposomal amphotericin B.
Pediatr Hematol Oncol. 2005 Jul-Aug;22(5):349-55. doi: 10.1080/08880010590964110.
5
Successful treatment of visceral leishmaniasis with liposomal amphotericin B.
Acta Biomed. 2006;77 Suppl 2:22-5.
6
U.S Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis.
Clin Infect Dis. 1999 Jan;28(1):49-51. doi: 10.1086/515086.
7
Diffuse cutaneous dissemination of visceral leishmaniasis during human immunodeficiency virus (HIV) infection, despite negligible immunodeficiency: repeated failure of liposomal amphotericin B administration, followed by successful long-term pentamidine and paromomycin administration.
Int J Antimicrob Agents. 2008 Jun;31(6):590-2. doi: 10.1016/j.ijantimicag.2008.02.007. Epub 2008 May 5.
8
Visceral leishmaniasis in renal transplant recipients: successful treatment with liposomal amphotericin B (AmBisome).
Clin Infect Dis. 1999 Jun;28(6):1308-9. doi: 10.1086/514784.
9
U.S. Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis.
Clin Infect Dis. 1999 Jan;28(1):42-8; discussion 49-51. doi: 10.1086/515085.
10
Treatment of visceral leishmaniasis unresponsive to pentamidine with amphotericin B.
J Assoc Physicians India. 1995 Apr;43(4):306.
引用本文的文献
1
Synthetic biology for combating leishmaniasis.
Front Microbiol. 2024 Feb 1;15:1338749. doi: 10.3389/fmicb.2024.1338749. eCollection 2024.
Zotero 插件